<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - FDA Authorizes Moderna's COVID-19 Vaccine
Image Overlay - FDA Authorizes Moderna's COVID-19 Vaccine

FDA Authorizes Moderna's COVID-19 Vaccine

FDA Authorizes Moderna's COVID-19 Vaccine

After approving Pfizer's COVID-19 vaccine three weeks ago, the FDA has now authorized Moderna's vaccine against the Coronavirus for individuals 18 years or older. The FDA based its recommendation on data analysis from the pivotal Phase III clinical study, which showed a primary vaccine efficacy rate of 94.1%. Under Operation Warp Speed, approximately 20 million doses will be delivered tp the U.S. government by the end of December 2020. As an organization, Yourway looks forward to supporting the massive vaccine distribution effort.

Back to Index
Media

Upcoming Events

Clinical Trial Supply East Coast 2022

October 19-20, 2022
King of Prussia, PA, USA

Media

Articles

Helping Sponsors Navigate Complex Ancillary Supply Sourcing Challenges with Integrated Services

Open chat
Come chat with us!
Hello! How can I help you?